This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of West Pharmaceutical Services Inc. plummeted 38.2% to $199.11 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.0% to 6,115.07 and the Dow Jones Industrial Average rising 0.8% to 44,711.43.
This was the stock's third consecutive day of losses.
West Pharmaceutical Services Inc. closed 50.3% short of its 52-week high of $400.88, which the company achieved on March 21st.
The stock underperformed when compared to some of its competitors, as Abbott Laboratories rose 1.0% to $131.79, Becton Dickinson & Co. fell 0.4% to $225.01, and Baxter International Inc. rose 1.09% to $30.62.
Trading volume totaled 5.1 million, compared to the 50-day average of 467,948.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 13, 2025 16:33 ET (21:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。